The Consortium for Translational and Precision Health (CTPH) is a partnership led by Baylor College of Medicine and the University of Houston, working to integrate translational research, informatics, and community health initiatives to improve personalized medicine.

Additionally, Baylor College of Medicine and the University of Houston received a $44.2 million grant to establish a regional hub for translational research, supporting infrastructure, services, and workforce development to accelerate health care innovations.

Precision health aims to tailor medical treatments and preventive strategies to individual patients based on genetic, environmental, and lifestyle factors. It integrates advanced data analytics, genomics, and personalized medicine to optimize health outcomes.

Together, late-stage translation and precision health work to ensure that medical innovations are effectively implemented and personalized for all populations, improving accessibility and effectiveness in health and healthcare.